Resverlogix
As of the edition of 20 October 2026, Resverlogix runs 1 drug.
Sources: ClinicalTrials.gov, FDA Orange Book and Purple Book, other approval registers, company records.
Drugs by status
| Status | Count |
|---|---|
| Active | 1 |
| Total | 1 |
Where its trials are
- Heart and blood vessels: 7 trials led
- Nutrition and metabolism: 6 trials led
- Hormones: 2 trials led